Prescription RequiredCrizalk 250mg Capsule contains Crizotinib, a targeted cancer therapy used to treat patients with non-small cell lung cancer (NSCLC) that is positive for ALK (anaplastic lymphoma kinase) or ROS1 gene rearrangements.
| Generic Name | Crizotinib |
| Manufacturer | Pfizer Ltd |
| Packing | 60 Capsules |
| Prescribed For | Lung Cancer |
| Availability | In Stock |
As a trusted supplier of anticancer medications, we provide authentic Crizalk (Crizotinib 250mg) capsules, widely used for the treatment of non-small cell lung cancer (NSCLC).
We ensure secure, reliable, and timely bulk supply of generic oncology drugs, including Crizotinib (Xalkori), to hospitals, clinics, pharmacies, healthcare institutions, physicians, NGOs, and authorized buyers worldwide. Our global distribution network spans over 80 countries across Latin America, Africa, Asia, Europe, the Middle East, and North America, covering key markets such as Mexico, Brazil, Colombia, Peru, Chile, UAE, Saudi Arabia, Egypt, South Africa, Namibia, Kenya, Nigeria, Singapore, Vietnam, Thailand, the Philippines, Canada, and many more.
Disclaimer
This website operates in compliance with applicable pharmaceutical laws. All content and data available on this website are intended solely for informational purposes. The information provided is not a substitute for professional medical advice, diagnosis, or treatment. Information provided here is for general awareness and does not replace medical advice. We strongly encourage you to consult a qualified healthcare professional for guidance.
